SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
25-NSE

25-NSE

Other
View HTML
CT ORDER

CT ORDER

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe